AN INVESTIGATION INTO INSULIN RESISTANCE IN PREDIABETIC PATIENTS USING THE HOMA2 MODEL AT CHO RAY HOSPITAL

Thành Vinh Trần, Văn Thanh Lê, Sang Đoàn, Hà Khánh Linh Dương

Main Article Content

Abstract

Background: Prediabetes is a health condition between normality and type 2 diabetes. The pathogenesis is based on insulin resistance. This study was conducted to analyze insulin resistance in prediabetic subjects. Objective: To determine the prevalence of insulin resistance according to the HOMA2 model in the prediabetic group, compared with the non-prediabetic control group. Subjects and Methods: The cross-sectional study collected data of 156 prediabetic and 152 non-prediabetic people from February 2023 to September 2023 at the Cho Ray Hospital Examination Department. Insulin resistance was determined using the HOMA2 model, the cut-off threshold being the 75th value of the control group. Prediabetes was diagnosed according to ADA 2022 standards. Results: The number of subjects selected to analyze was 144 people with prediabetes and 122 people without prediabetes. The prevalence of insulin resistance in the prediabetic group was 55.6%, which was statistically significant different from the non-prediabetic group of 24.6%. The HOMA2-IR (Median [IQR]) value in the prediabetes group was 1.40 (0.92 – 2.07), which was statistically significant higher than in the non-preiabetic group of 0.94 (0.60 – 1.29), P < 0.001. Conclusions: The prevalence of insulin resistance in people with diabetes was 55.6%, statistically significant greater than in the non-diabetic group of 24.6%, P < 0.001

Article Details

References

1. International Diabetes Federation. IDF Diabetes Atlas. IDF; 2021. https://www.diabetesatlas.org
2. American Diabetes Association Professional Practice C. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2022. Diabetes Care. Jan 1 2022;45(Suppl 1):S17-S38. doi:10.2337/dc22-S002
3. Phạm Hữu Tiến VNT, Mai Lệ Huyền, Vũ Trần Thiên Vũ, Phạm Yến Cẩm Mi. Nghiên cứu tình hình tiền đái tháo đường trên bệnh nhân tăng huyết áp và các yếu tố liên quan. Tại chí Y học Việt Nam. 2022; 515(2): 315-319. doi: https://doi.org/10.51298/vmj.v515i2.2817
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. Jul 1998;15(7):539-53. doi: 10.1002/ (SICI)1096-9136 (199807) 15:7 <539::AID-DIA668>3.0.CO;2-S
5. Matli B, Schulz A, Koeck T, et al. Distribution of HOMA-IR in a population-based cohort and proposal for reference intervals. Clin Chem Lab Med. Oct 26 2021;59(11): 1844-1851. doi:10. 1515/cclm-2021-0643
6. Đỗ Đình Tùng KPPV, Tạ Văn Bình,. Nghiên cứu chức năng tế bào beta, độ nhạy insulin ở người tiền đái tháo đường khu vực Hà Nội. Tạp chí Y học Việt Nam. 2023;525(2):198-203. doi: https://doi.org/10.51298/vmj.v525i2.5222
7. Nguyễn Thị Duyên và Bùi Tuấn Anh. Nghiên cứu nồng độ IL-6 huyết tương, chỉ số HOMA2-IR trên bệnh nhân đái tháo đường type 2. Tạp chí Y học Việt Nam. 23/12/2021 2021;507(2) doi: https://doi.org/10.51298/vmj.v507i2.1410